Methods for detection, isolation and culture of mouse and human invariant NKT cells (original) (raw)
Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. & Wakao, H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol.21, 483–513 (2003). ArticleCAS Google Scholar
Wilson, S.B. & Delovitch, T.L. Janus-like role of regulatory _i_NKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol.3, 211–222 (2003). ArticleCAS Google Scholar
Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d restricted natural killer T cell activation during microbial infection. Nat. Immunol.4, 1230–1237 (2003). ArticleCAS Google Scholar
Taniguchi, M., Seino, K. & Nakayama, T. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol.4, 1164–1165 (2003). ArticleCAS Google Scholar
Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R.M. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med.198, 267–279 (2003). ArticleCAS Google Scholar
Lantz, O. & Bendelac, A. An invariant T cell receptor α chain is used by a unique subset of MHC class I-specific CD4+ and CD4-8 T cells in mice and humans. J. Exp. Med.180, 1097–1106 (1994). ArticleCAS Google Scholar
Exley, M., Garcia, J., Balk, S.P. & Porcelli, S. Requirements for CD1d recognition by human invariant Vα24+CD4CD8 T cells. J. Exp. Med.186, 109–120 (1997). ArticleCAS Google Scholar
Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science306, 1786–1789 (2004). ArticleCAS Google Scholar
Speak, A.O. et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA104, 5971–5976 (2007). ArticleCAS Google Scholar
Porubsky, S. et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA104, 5977–5982 (2007). ArticleCAS Google Scholar
Morita, M. et al. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem.38, 2176–2187 (1995). ArticleCAS Google Scholar
Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science278, 1626–1629 (1997). ArticleCAS Google Scholar
Borg, N.A. et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature.448, 44–49 (2007). ArticleCAS Google Scholar
Tynan, F.E. et al. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol.6, 1114–1122 (2005). ArticleCAS Google Scholar
Kawakami, K. et al. Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol.33, 3322–3330 (2003). ArticleCAS Google Scholar
Nieuwenhuis, E.E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med.8, 588–593 (2002). ArticleCAS Google Scholar
Gonzalez-Aseguinolaza, G. et al. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med.195, 617–624 (2002). ArticleCAS Google Scholar
Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science278, 1623–1626 (1997). ArticleCAS Google Scholar
Smyth, M.J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med.191, 661–668 (2000). ArticleCAS Google Scholar
Nakagawa, R. et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J. Immunol.166, 6578–6584 (2001). ArticleCAS Google Scholar
Kojo, S. et al. Induction of regulatory properties in dendritic cells by Valpha14 NKT cells. J. Immunol.175, 3648–3655 (2005). ArticleCAS Google Scholar
Hammond, K.J. et al. α/β-T cell receptor (TCR)+ CD4−CD8− (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med.187, 1047–1056 (1998). ArticleCAS Google Scholar
Nakamura, T. et al. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol.171, 1266–1271 (2003). ArticleCAS Google Scholar
Ikehara, Y. et al. CD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest.105, 1761–1767 (2000). ArticleCAS Google Scholar
Seino, K.I. et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA98, 2577–2581 (2001). ArticleCAS Google Scholar
Liu, Y. et al. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods312, 34–39 (2006). ArticleCAS Google Scholar
Greten, T.F. et al. Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J. Immunol. Methods271, 125–135 (2002). ArticleCAS Google Scholar
Naidenko, O.V. et al. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med.190, 1069–1080 (1999). ArticleCAS Google Scholar
Hammond, K.J.L. et al. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol.167, 1164–1173 (2001). ArticleCAS Google Scholar
Sidobre, S. & Kronenberg, M. CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J. Immunol. Methods268, 107–121 (2002). ArticleCAS Google Scholar
Karadimitris, A.S. et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA98, 3294–3298 (2001). ArticleCAS Google Scholar